Altamira Therapeutics Ltd

:EARS   3:59:50 PM EDT
3.14
+0.23 (+7.90%)
Products, Regulatory

Auris Medical To Develop Kras-Targeting Rna Treatment For Colorectal Cancer As First Therapeutic Indication For Oligophore™ Technology

Published: 07/06/2021 13:39 GMT
(EARS) - Auris Medical to Develop Kras-targeting Rna Treatment for Colorectal Cancer As First Therapeutic Indication for Oligophore™ Technology.
Auris Medical Holding Ltd - Treatment of Kras-driven Colorectal Cancer Selected As First Therapeutic Indication for Oligophore™ Platform.
Auris Medical Holding Ltd - Company to Launch Development Program Under Project Code Am-401 With Aim of Ind Submission in Late 2022.